The purpose of this systematic review and meta-analysis is to explore the factors associated with medication engagement among older adults (≥60 years) with diabetes.
Methods
Five databases (PubMed, Embase, Cumulative Index to Nursing and Allied Health Literature, PsycINFO, and Scopus) were systematically searched to identify studies examining the association between factors and medication engagement among older diabetes patients. A study met inclusion for meta-analysis if the prevalence of medication engagement or factor was reported in ≥2 studies and the frequency or strength of association was either reported or able to be computed. Quality appraisal was performed with the Downs and Black tool.
Results
Of 538 retrieved studies, 33 (20 cohort and 13 cross-sectional) were included for systematic review; of these, 22 met criteria for meta-analysis. Findings from meta-analysis show that women (odds ratio [OR], 0.92; 95% CI, 0.86-0.97), those with depression (OR, 0.73; 95% CI, 0.62-0.87), and those with higher out-of-pocket spending for prescription drugs (OR, 0.87; 95% CI, 0.80-0.94) were less likely to take diabetes medication when compared with men, those without depression, and those with lower out-of-pocket costs, respectively. Older age (OR, 1.13; 95% CI, 1.00-1.27) was associated with better engagement to diabetes medication.
Conclusions
Of 4 identified factors, 2 are modifiable. Recent policy efforts to decrease the cost burden of prescribed medication for older adults, such as Medicare Part D, may remove this barrier to medication engagement. Routine screening for depression among older adults with diabetes should be included as part of usual care to facilitate an integrated treatment approach.
Get full access to this article
View all access options for this article.
References
1.
US Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: US Centers for Disease Control and Prevention; 2014.
2.
PietteJDHeislerMWagnerTH.Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27(2):384-391.
3.
MunshiMNSegalARSuhlEet al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med. 2011;171(4):362-364.
4.
DickinsonJKGuzmanSJMaryniukMDet al. The use of language in diabetes care and education. Diabetes Educ. 2017;43(6):551-564.
5.
HuberCARapoldRBrunggerBReichORosemannT.One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: an observational study. Medicine (Baltimore). 2016;95(26):e3994.
6.
CramerJABenedictAMuszbekNKeskinaslanAKhanZM.The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62(1):76-87.
7.
IMS Institute for Healthcare Informatics. Avoidable Costs in US Healthcare. Parsippany, NJ: IMS Institute for Healthcare Informatics; 2013.
8.
HoPMRumsfeldJSMasoudiFAet al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-1841.
9.
BreitscheidelLStamenitisSDippelFWSchoffskiO.Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper. J Med Econ. 2010;13(1):8-15.
10.
HepkeKLMartusMTShareDA.Costs and utilization associated with pharmaceutical adherence in a diabetic population. Am J Manag Care. 2004;10(2, pt 2):144-151.
11.
SalasMHughesDZuluagaAVardevaKLebmeierM.Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value Health. 2009;12(6):915-922.
CapocciaKOdegardPSLetassyN.Medication adherence with diabetes medication: a systematic review of the literature. Diabetes Educ. 2016;42(1):34-71.
14.
CramerJA.A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-1224.
15.
KrassISchiebackPDhippayomT.Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725-737.
16.
GelladWFGrenardJLMarcumZA.A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11-23.
17.
BalkrishnanRRajagopalanRCamachoFTHustonSAMurrayFTAndersonRT.Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958-2971.
18.
GazmararianJAKripalaniSMillerMJEchtKVRenJRaskK.Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006;21(12):1215-1221.
19.
MoherDLiberatiATetzlaffJAltmanDGGroupP.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269, W264.
20.
GelladWFGrenardJMcGlynnEA.A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. Santa Monica, CA: RAND Health; 2009.
21.
DownsSHBlackN.The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377-384.
22.
DhippayomTKrassI.Medication-taking behaviour in New South Wales patients with type 2 diabetes: an observational study. Aust J Prim Health. 2015;21(4):429-437.
23.
GuQZengFPatelBVTripoliLC.Part D coverage gap and adherence to diabetes medications. Am J Manag Care. 2010;16(12):911-918.
24.
HansenRAVoilsCIFarleyJFet al. Prescriber continuity and medication adherence for complex patients. Ann Pharmacother. 2015;49(3):293-302.
25.
IyengarRNBalagereDSHendersonRRLeFrancoisALRabbittRMFranzeeSG.Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol. J Manag Care Spec Pharm. 2014;20(8):851-861.
26.
DonnanPTMacDonaldTMMorrisAD.Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002;19(4):279-284.
27.
KilbourneAMReynoldsCFIIIGoodCBSereikaSMJusticeACFineMJ.How does depression influence diabetes medication adherence in older patients?Am J Geriatr Psychiatry. 2005;13(3):202-210.
28.
MananMMHusinARAlkhoshaibanASAl-WorafiYMMingLC.Interplay between oral hypoglycemic medication adherence and quality of life among elderly type 2 diabetes mellitus patients. J Clin Diagn Res. 2014;8(12):JC05-JC09.
29.
Vittorino GaddiABenedettoDCapelloFet al. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens. Public Health. 2014;128(1):70-76.
30.
KirkmanMSRowan-MartinMTLevinRet al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015;38(4):604-609.
31.
YangYThumulaVPacePFBanahanBFIIIWilkinNELobbWB.Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther. 2009;31(10):2178-2188.
32.
BellRAAndrewsJSArcuryTASnivelyBMGoldenSLQuandtSA.Depressive symptoms and diabetes self-management among rural older adults. Am J Health Behav. 2010;34(1):36-44.
33.
KatonWRussoJLinEHet al. Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?Psychosom Med. 2009;71(9):965-972.
34.
LinEHKatonWVon KorffMet al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154-2160.
35.
WongESMaciejewskiMLLiuCF.Does the association between prescription copayment increases and medication adherence differ by race?J Health Care Poor Underserved. 2013; 24(3):1317-1330.
36.
HigginsJPThompsonSGDeeksJJAltmanDG.Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
37.
EggerMDavey SmithGSchneiderMMinderC.Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109): 629-634.
38.
EgedeLEGebregziabherMHuntKJet al. Regional, geographic, and ethnic differences in medication adherence among adults with type 2 diabetes. Ann Pharmacother. 2011;45(2):169-178.
39.
FrenchDPWadeANFarmerAJ.Predicting self-care behaviours of patients with type 2 diabetes: the importance of beliefs about behaviour, not just beliefs about illness. J Psychosom Res. 2013;74(4):327-333.
40.
GrandySFoxKMHardyE; SHIELD Study Group. Association of weight loss and medication adherence among adults with type 2 diabetes mellitus: SHIELD (Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes). Curr Ther Res Clin Exp. 2013;75:77-82.
41.
WhiteAJKellarIPrevostATet al. Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care. Prim Care Diabetes. 2012;6(1):27-33.
42.
CheongCBarnerJCLawsonKAJohnsrudMT.Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Clin Ther. 2008;30(10):1893-1907.
43.
ChristensenAJHowrenMBHillisSLet al. Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence. J Gen Intern Med. 2010;25(5):397-402.
44.
ColombiAMYu-IsenbergKPriestJ.The effects of health plan copayments on adherence to oral diabetes medication and health resource utilization. J Occup Environ Med. 2008;50(5):535-541.
45.
KocarnikBMLiuCFWongESet al. Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence?BMC Health Serv Res. 2012;12:391.
46.
LopezJMAnnunziataKBaileyRARupnowMFMoriskyDE.Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence. Patient Prefer Adherence. 2014;8:683-692.
47.
DuruOKSchmittdielJADyerWTet al. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010;16(1):33-40.
48.
GonzalezJSDelahantyLMSafrenSAMeigsJBGrantRW.Differentiating symptoms of depression from diabetes-specific distress: relationships with self-care in type 2 diabetes. Diabetologia. 2008;51(10):1822-1825.
49.
GrantRWDevitaNGSingerDEMeigsJB.Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5):1408-1412.
50.
HankoBKazmerMKumliPet al. Self-reported medication and lifestyle adherence in Hungarian patients with type 2 diabetes. Pharm World Sci. 2007;29(2):58-66.
51.
HeislerMColeIWeirDKerrEAHaywardRA.Does physician communication influence older patients’ diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci. 2007;62(12):1435-1442.
52.
PietteJDHeislerMKreinSKerrEA.The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165(15):1749-1755.
53.
SchmittdielJANicholsGADyerWSteinerJFKarterAJRaebelMA.Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015;53(4):332-337.
54.
SchoenthalerAMSchwartzBSWoodCStewartWF.Patient and physician factors associated with adherence to diabetes medications. Diabetes Educ. 2012;38(3):397-408.
55.
WalkerRJGebregziabherMMartin-HarrisBEgedeLE.Independent effects of socioeconomic and psychological social determinants of health on self-care and outcomes in type 2 diabetes. Gen Hosp Psychiatry. 2014;36(6):662-668.
56.
GonzalezJSPeyrotMMcCarlLAet al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398-2403.
57.
GrenardJLMunjasBAAdamsJLet al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26(10):1175-1182.
58.
ManteuffelMWilliamsSChenWVerbruggeRRPittmanDGSteinkellnerA.Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health (Larchmt). 2014;23(2):112-119.
59.
Thunander SundbomLBingeforsK. Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey. Pharm Pract (Granada). 2012;10(4):207-221.
60.
ChoiYJJiaHGrossTWeingerKStonePWSmaldoneAM.The impact of Medicare Part D on the proportion of out-of-pocket prescription drug costs among older adults with diabetes. Diabetes Care. 2017;40(4):502-508.
61.
YaffeKFalveyCHamiltonNet al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69(9):1170-1175.
62.
WesselsAMLaneKAGaoSHallKSUnverzagtFWHendrieHC.Diabetes and cognitive decline in elderly African Americans: a 15-year follow-up study. Alzheimers Dement. 2011;7(4):418-424.
63.
LogroscinoGKangJHGrodsteinF.Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ. 2004;328(7439):548.
64.
LuchsingerJAPalmasWTeresiJAet al. Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging. 2011;15(6):445-449.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
